Evidence map›Paper›PMID 34063628›Full record

ArticleMarine drugs2021

Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells.

Somruethai Sumkhemthong, Supakarn Chamni, Gea U Ecoy, Pornchanok Taweecheep, Khanit Suwanborirux, Eakachai Prompetchara, Pithi Chanvorachote, Chatchai Chaotham

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Somruethai SumkhemthongDepartment of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
Supakarn ChamniDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-8941-1046
Gea U EcoyDepartment of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0001-5705-1376
Pornchanok TaweecheepDepartment of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
Khanit SuwanboriruxDepartment of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
Eakachai PrompetcharaDepartment of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Pithi ChanvorachoteDepartment of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-3103-3249
Chatchai ChaothamDepartment of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.ORCID 0000-0002-3206-192X
Chulalongkorn University · TH

Funding

Chulalongkorn University 90th Anniversary of Chulalongkorn UniversityChulalongkorn University Ratchadaphiseksomphot Endowment Fund (grant no. CU_GR_62_20_33_01)National Research Council of Thailand (NRCT) Mid-Career Research Grant (RSA 6280009)
6 · The paper itself

Abstract

It has been recognized that cancer stem-like cells (CSCs) in tumor tissue crucially contribute to therapeutic failure, resulting in a high mortality rate in lung cancer patients. Due to their stem-like features of self-renewal and tumor formation, CSCs can lead to drug resistance and tumor recurrence. Herein, the suppressive effect of jorunnamycin A, a bistetrahydroisoquinolinequinone isolated from Thai blue sponge

Indexed as

AnimalsApoptosisCell Line, TumorCell ProliferationCell SurvivalCisplatinDown-RegulationDrug SynergismHumansIsoquinolinesLung NeoplasmsNanog Homeobox ProteinNeoplastic Stem CellsOctamer Transcription Factor-3Proto-Oncogene Proteins c-bcl-2QuinolonesBCL2 protein, humanCisplatinIsoquinolinesjorunnamycin ANanog Homeobox ProteinNANOG protein, humanOctamer Transcription Factor-3POU5F1 protein, humanProto-Oncogene Proteins c-bcl-2QuinolonesSOX2 protein, humanSOXB1 Transcription FactorsTP53 protein, humanTranscription FactorsTumor Suppressor Protein p53cancer stem-like cellscisplatinjorunnamycin Alung cancerstemness transcription factorsβ-catenin

Identifiers

PMID34063628
PMCPMC8147647
OpenAlexW3159036808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.